Hematopoietic chimerism resulting from prenatal marrow transplantation does not consistently result in allotolerance for unidentified causes. In a C57BL/6-into-FVB/N murine model, we transplanted T-cell-depleted adult marrow on gestational day 14 to elucidate the immunological significance of chimerism towards postnatal tolerance. Postnatally, chimerism was examined by flow cytometry, and tolerance by skin transplantation and mixed lymphocyte reaction. Regulatory T cells were quantified by FoxP3 expression. Peripheral chimerism linearly related to thymic chimerism, and predicted the degree of graft acceptance with levels >3% at skin placement, yielding consistent skin tolerance. Low-and high-level chimeras had lower intrathymic CD3 high expression than microchimeras or untransplanted mice. Regardless of the skin tolerance status in mixed chimeras, donor-specific alloreactivity by lymphocytes was suppressed but could be partially restored by exogenous interleukin-2. Recipients that lost peripheral chimerism did not accept donor skin unless prior donor skin had engrafted at sufficient chimerism levels, suggesting that complete tolerance can develop as a consequence of chimerism-related immunosuppression of host lymphocytes and the tolerogenic effects of donor skin. Thus, hematopoietic chimerism exerted immunomodulatory effects on the induction phase of allograft tolerance. Once established, skin tolerance did not fade away along with spontaneous regression of peripheral and tissue chimerism, as well as removal of engrafted donor skin. Neither did it break following in vivo depletion of increased regulatory T cells, and subcutaneous interleukin-2 injection beneath the engrafted donor skin. Those observations indicate that the maintenance of skin tolerance is multifaceted, neither solely dependent upon hematopoietic chimerism and engrafted donor skin nor on the effects of regulatory T cells or clonal anergy. We conclude that hematopoietic chimerism generated by in utero hematopoietic stem cell transplantation is critical to establish rather than maintain postnatal skin tolerance. Therefore, the diminution of hematopoietic chimerism below a threshold level does not nullify an existing tolerance state, but lessens the chance of enabling complete tolerance.
Hematopoietic chimerism resulting from prenatal marrow transplantation does not consistently result in allotolerance for unidentified causes. In a C57BL/6-into-FVB/N murine model, we transplanted T-cell-depleted adult marrow on gestational day 14 to elucidate the immunological significance of chimerism towards postnatal tolerance. Postnatally, chimerism was examined by flow cytometry, and tolerance by skin transplantation and mixed lymphocyte reaction. Regulatory T cells were quantified by FoxP3 expression. Peripheral chimerism linearly related to thymic chimerism, and predicted the degree of graft acceptance with levels >3% at skin placement, yielding consistent skin tolerance. Low-and high-level chimeras had lower intrathymic CD3 high expression than microchimeras or untransplanted mice. Regardless of the skin tolerance status in mixed chimeras, donor-specific alloreactivity by lymphocytes was suppressed but could be partially restored by exogenous interleukin-2. Recipients that lost peripheral chimerism did not accept donor skin unless prior donor skin had engrafted at sufficient chimerism levels, suggesting that complete tolerance can develop as a consequence of chimerism-related immunosuppression of host lymphocytes and the tolerogenic effects of donor skin. Thus, hematopoietic chimerism exerted immunomodulatory effects on the induction phase of allograft tolerance. Once established, skin tolerance did not fade away along with spontaneous regression of peripheral and tissue chimerism, as well as removal of engrafted donor skin. Neither did it break following in vivo depletion of increased regulatory T cells, and subcutaneous interleukin-2 injection beneath the engrafted donor skin. Those observations indicate that the maintenance of skin tolerance is multifaceted, neither solely dependent upon hematopoietic chimerism and engrafted donor skin nor on the effects of regulatory T cells or clonal anergy. We conclude that hematopoietic chimerism generated by in utero hematopoietic stem cell transplantation is critical to establish rather than maintain postnatal skin tolerance. Therefore, the diminution of hematopoietic chimerism below a threshold level does not nullify an existing tolerance state, but lessens the chance of enabling complete tolerance.
INTRODUCTION
acquired immune tolerance to allografts was first demonstrated in Medawar and colleagues' study using preemptive exposure of donor cells (3) . Subsequently, toler-Based upon the observation that sharing of fetal blood is sufficient to enable skin graft acceptance (4, 32) , ance was produced by marrow cell infusion in irradiated adult recipients prior to or at the time of organ transplan-the levels of peripheral chimerism required for postnatal skin tolerance, clarify the causal relationship between tation (18, 29, 31) . With the discovery of trace donor leukocytes in the tissues or blood of long-surviving organ chimerism and donor-specific tolerance, and investigate possible peripheral mechanisms involved in immune tol-recipients in 1992, Starzl et al. (38, 39) and Wood and Sachs (46) proposed that immunological tolerance erance after IUT of bone marrow. achieved either by bone marrow or solid organ trans-MATERIALS AND METHODS plantation is linked by a common dependence on the presence of hematopoietic chimerism. Thereafter, this
Mouse Husbandry concept has influenced our thinking about tolerance and Inbred FVB/N (H-2 q , Thy1.1), C57BL/6 (H-2 b , rejection of organs in modern transplantation immunol-Thy1.2), and C3H (H-2 k ) mice were purchased from Naogy, fueling high expectations for experimental maniputional Laboratory Animal Center (Taipei, Taiwan) at the lations of donor cell chimerism to improve tolerance inage of 6-8 weeks, and housed in the Animal Care Facilduction.
ity at Chang Gung Memorial Hospital under the stan-There is no shortage of experimental strategies for dard guidelines from Guide for the Care and Use of tolerance induction through the creation of mixed chi-Laboratory Animals and with the approval of the Commerism in postnatal life (45). Despite years of effort mittee on Animal Research. Recipient FVB/N females with animal studies, questions remain as to the relationwere caged with FVB/N males in the afternoon and ship of hematopoietic chimerism to tolerance. In rat chichecked for vaginal plugs the following morning. The meras with skin tolerance, the abolition of chimerism by day when the plug was observed was designated as day antidonor antisera caused the rejection of engrafted do-0 of the pregnancy. nor skin within 12 h after serum injection (28) . This hyperacute graft rejection is most likely procured by di-Bone Marrow Cell (BMC) Preparation and IUT rect inimical effects of antibodies to the alloantigens ex-Adult BMCs from C57BL/6 mice (8-24 weeks of pressed on vascular endothelia of the graft (27) rather age) were harvested by flushing the tibias and femurs than by the abolition of chimerism. Further studies conwith phosphate-buffered saline (PBS) using a 26-gauge ducted in mice (22, 35) showed that the elimination of needle. Light-density BMCs were obtained by layering donor cells from established mixed chimeras with anti-BMCs over NycoPrep 1.077A (Nycomed, Pharma AS, donor major histocompatibility complex (MHC) anti-Oslo, Norway) and centrifuging at 600 × g for 25 min. body caused the failure of skin acceptance rather than Light-density BMCs were then depleted of T cells by the rejection of engrafted skin. This observation was inanti-CD3 FITC (BioLegend, San Diego, CA) and antiterpreted as the recipients' inability to maintain toler-FITC microbeads (Miltenyi Biotec, Auburn, CA) to obance due to the loss of chimerism, based on the assumptain T-cell-depleted BMCs that contained less than 0.5% tion that there had been existing tolerance resulting from of CD3 + cells and 2.22-4.74% of CD11c + cells. Within hematopoietic chimerism. However, it is not always the 3 h after preparation, IUT of 5-10 × 10 6 T-cell-depleted case that hematopoietic chimerism yields complete tol-BMCs in 5-10 µl PBS was performed as previously deerance and the acceptance of tissue grafts (25, 30) , espescribed (7, 8) . Recipients with any clinical sign of graftcially with microchimerism (11, 17, 33) . Moreover, chiversus-host disease were disqualified for enrollment. merism and skin tolerance may be maintained by different mechanisms (48) . Evidence also shows that Harvests of Peripheral Blood and Tissues graft tolerance can persist despite the loss of peripheral chimerism (20, 21, 23, 37) . It is worth mentioning that the Regular blood sampling was performed via the tail tip after restraint and thymic biopsy through a supraster-preconditioning or immunosuppressive programs required for postnatal bone marrow transplantation poten-nal incision under anesthesia. Harvests of spleen, bone marrow, lymph node, thymus, and peritoneal cells de-tially interfere with the assessment of hematopoietic chimerism and graft tolerance because they can delay the manded a sacrifice procedure. To avoid contamination by cells from different tissues, peripheral blood, if nec-rejection of skin grafts (14) or suppress the elimination of donor leukocytes (46) . essary, was first sampled from axillary or neck vessels. Then, peritoneal cells were obtained by flushing the In utero transplantation (IUT) provides a unique approach to generating allogeneic hematopoietic chime-peritoneal cavity with 10 ml PBS. Subsequently, BMCs were harvested by flushing the tibias and femurs with rism as well as inducing postnatal tolerance to donorspecific grafts without artificially suppressing the host's PBS. At last, the spleen, lymph node, and thymus (or its remnant) were removed, washed with PBS, and dissoci-immune system. However, conflicting experimental observations pertaining to tolerance and chimerism remain ated by passage through 70-µm cell strainers (BD Biosciences, Bedford, MA) to obtain cells for analyses. in the setting of IUT (5, 12) . This prompted us to study Analyses of Chimerism culated using mean cpm divided by mean background cpm (responder cells only). Samples were depleted of red cells using ACK Clonal anergy was evaluated by supplementing buffer, pH 7.2-7.4, consisting of 0.15 M NH 4 Cl, 1.0 mixed lymphocyte cultures with interleukin-2 (IL-2, mM KHCO 3 , and 0.1 mM Na 2 EDTA (Sigma Chemical PeproTech, Rocky Hill, NJ) at 2 and 10 ng/ml. Addi-Co., St. Louis, MO). Cells were first incubated with tionally, some mice with long-term skin acceptance reanti-mouse CD16/32 antibody (Clone 93, BioLegend) to ceived subcutaneous injection of 4 µg IL-2 beneath the lessen nonspecific Fc-mediated binding of monoclonal engrafted donor skin, followed by 2 µg IL-2 daily for 5 antibodies, and then stained with anti-H-2K q FITC (Bioconsecutive days. Engrafted skin was then monitored for Legend) and anti-H-2K b PE (BioLegend). A negative 30 days. control consisted of anti-H-2K q FITC and mouse IgG2a PE (BioLegend) to define background staining. Thymic
Quantification and Functional Test of Regulatory chimerism was further examined by staining the thymo-T Cells (Tregs) cytes with anti-Thy1.1 FITC (Clone OX-7, BioLegend)
Peripheral blood was sampled and depleted of red and anti-Thy1.2 PE (Clone 30-H12, BioLegend). Lincells using ACK lysing buffer. Flow cytometric analyses eage analyses for thymic chimerism were carried out uswere performed after intracellular staining of FoxP3 using anti-H-2K b PE and either FITC-labeled anti-CD3 , ing Mouse Treg Flow TM Kit (BioLegend). Tregs were -CD4, -CD8, -CD45R, -CD11b, -CD11c, or -Gr1 (Bioquantified by the expression of FoxP3 and CD25 in Legend). After gating out dead cells using propidium CD4 + cells. Real-time PCR was also used to evaluate iodide, 100,000 events were acquired for analyses of FoxP3 expression in splenic CD4 + cells enriched by poschimerism levels and 50,000 events for lineage analyses.
itive selection using Mouse CD4 MicroBeads (Miltenyi The sensitivity of chimerism analyses by flow cytometry Biotec). Total mRNA were extracted from enriched is 0.01%.
CD4 + cells (>95%) with RNeasy Mini Kit (Qiagen K.K., Tokyo, Japan). First-strand cDNA were reversely tran-Skin Transplantation scribed from mRNA templates of each sample in equal Skin transplantation was performed within 3 days amount, using MMLV High Performance Reverse Tranafter the examination of chimerism, using tail skins from scriptase Kit with an oligo(dT) primer (EPICENTRE FVB/N (syngeneic), C57BL/6 (donor-specific), and Biotechnologies, Madison, WI). Then, target gene ex-C3H mice (third-party). After the removal of dressings pression was quantified by TaqMan Gene Expression on day 7, grafts were monitored daily for the first month Assays (Applied Biosystems, Foster City, CA), consistand then at least twice a week thereafter until both ing of unlabeled PCR primers for FoxP3 (Assay ID: C57BL/6 and C3H skin grafts were rejected or C57BL/ Mm00475165_m1) or GAPDH (Assay ID: Mm999 6 skin engrafted for at least 4 months after skin trans-99915_g1) and TaqMan MGB probe (FAM TM dye laplantation. Engrafted skin was defined by good hair beled). Normalized value for FoxP3 mRNA expression growth and examined by hematoxylin-eosin staining in each sample was calculated as the relative quantity of after its removal. Rejection was defined as when ≤20%
FoxP3 divided by the relative quantity of GAPDH. of the original graft remained. A tolerant state was de-
The inhibitory function of Tregs on alloreactivity was fined by skin engraftment for at least 120 days. evaluated by MLR. Tregs were enriched from splenocytes of tolerant animals using Mouse CD4
ulatory T-cell Isolation Kit (Miltenyi Biotec). MLR was and Anergy Evaluation conducted in 200 µl RPMI-1640 medium that contained 5 × 10 4 responder cells from untransplanted FVN/B Splenic lymphocytes were enriched with NycoPrep 1.077A density gradient. Responders were lymphocytes mice and 2 × 10 5 irradiated stimulator cells from FVB/ N, C57BL/6, or C3H mice with addition of 5 × 10 4 from FVB/N mice and stimulators were 3,000 cGy irradiated lymphocytes from FVB/N, C57BL/6, and C3H
Tregs from tolerant mice. Proliferation was measured on day 4 as described for MLR. mice. Briefly, 2 × 10 5 responder cells were cultured in 200 µl RPMI-1640 medium (Life Technologies, Grand
In Vivo Depletion of Tregs Island, NY) for 4 days with 6 × 10 5 stimulator cells at 37°C in a humidified, 5% CO 2 -containing incubator.
For in vivo Treg depletion, mice with long-term skin tolerance and loss of peripheral chimerism were intra-Then, [ 3 H]thymidine (ICN Biomedicals, Costa Mesa, CA) was added at a final concentration of 1 µCi/well. peritoneally injected with 0.25 mg anti-CD25 (Clone PC61, BioLegend). Tregs were quantified by intracellu-The next day, cells were harvested for counting incorporated 3 H in a liquid scintillation counter (1450 Microbeta lar FoxP3 staining 1 day before and 1 week after PC61 injection. Plus counter, Wallac, OH). Stimulation indices were cal-
Intravenous Injection of Naive Host Splenic thymic H-2K b− CD3 high cells (Fig. 1D). Overall thymic CD3 high expression was significantly lower in low-and Lymphocytes in Tolerant Mice
high-level chimeras than in microchimeras and untrans-Naive lymphocytes were enriched from untransplanted controls ( Fig. 1E ). planted FVB/N splenocytes, using NycoPrep 1.077A density gradient. Cells were injected via tail vein in mice Durability of Chimerism, and Association Between Skin with skin tolerance. Engrafted syngeneic and donor Transplantation Timing and Skin Graft Survival skins were then monitored daily.
We first collected 48 recipients with peripheral chimerism of 0.01-8.75% at the age of 1 month to deter-Statistical Analyses mine the durability of their chimerism by monthly flow Because the distribution of donor cell levels was obcytometric examination ( Fig. 2A) . These data were then viously skewed to the right (positive skew), nonparametused to categorize 147 recipients with first month peric tests were used to measure the significance of differripheral chimerism of <10% into three groups of <0.5%, ences in chimerism levels between two (Mann-Whitney 0.5-1.99%, and ≥ 2% as M1(<0.5), M1(0.5-1.99), and U-test) or more (Kruskal-Wallis H-test) independent M1(≥2), respectively. To evaluate whether the timing of groups. Wilcoxon signed-ranks test was used to compare skin transplantation could influence skin graft survivals, paired medians of chimerism levels at two different time we further subgrouped the recipients in each group arbipoints from recipients of test groups. Spearman's rank trarily by the timing of skin transplantation at the ages correlation coefficient (rho) was computed to evaluate of 1 (ST1), 2 (ST2), or 6 months (ST6). the bivariate correlation of thymic and peripheral chime-Chimerism levels at 1 month of age were similar rism. The equality of means for MLR data, thymic linamong skin transplant subgroups ( Fig. 2B ), but signifieage expressions, and Treg proportions was examined cantly decreased at the second and sixth month time by Student's t-test between two independent groups, or points of skin transplantation (Fig. 2C) . Paired comparione-way ANOVA among three or more groups with son of donor cell levels for each recipient between the post hoc multiple comparison test by least significant first and second or sixth month further indicated that the difference. As for survival analysis of skin transplants, decline in chimerism was significant (p = 0.001-0.006). the survival time was defined by estimating the length Earlier skin placement benefited the survivals of donor of time from the date of skin transplantation to the date skin grafts in groups M1(0.5-1.99) and M1(≥2) (Fig. of graft rejection or the date of last follow-up. Other-2D), but not in group M1(<0.5) despite that two recipiwise, the graft was considered censored at last followents in subgroup M1(<0.5)ST1 had long-term skin tolerup. When a mouse died before skin rejection was obance ( Table 1 ). All syngeneic skin grafts survived well served, it was counted as a withdrawal and treated the during the period of graft monitoring, but third-party same way as cases lost to follow-up. Plots of survival skin grafts were rejected within 2-3 weeks without sigtime were constructed by Kaplan-Meier method. The log nificant difference among any of the subgroups. These rank test was employed to compare survival curves. Diffindings indicate that skin graft survivals in recipients ferences were regarded as significant in all tests when with transient chimerism are affected by the timing of p < 0.05. skin transplantation, but it is limited by chimerism levels at 1 month of age. RESULTS
Analyses of Thymic Chimerism
Relationship of Peripheral Chimerism Levels at the Time of Skin Transplantation to Skin Survival Thymic biopsy was performed to examine thymic chimerism using donor H-2K b antigen within 1 day after A scatterplot illustrates the relationship between chimerism levels at the time of skin transplantation and peripheral chimerism was measured at the age of 1 month. A linear relationship was found between periph-graft survival times (Fig. 3A ). Survival analyses ( Fig.  3B ) showed that chimerism levels of >3% consistently eral and thymic H-2K b+ chimerism (Fig. 1A) . Thymic chimerism is estimated at about one third of peripheral chi-correlated with long-term graft acceptance of >120 days, but a level of 0.2-3% only stood a 34% chance of long-merism in terms of H-2K b+ donor cells. T cells (CD3 high , 4 + , or 8 + ) were the major donor cell type engrafted in term skin tolerance. Recipients with a chimerism level of <0.2% never accepted grafts for >60 days, but their the thymus (Fig. 1B) , accounting for 50-70% of donor cells in low-or high-level chimeras (Fig. 1C ). Regard-transient graft survivals were still superior to untransplanted controls. This indicates that recipients with pe-less of donor or host origin, CD45R, CD11b, CD11c, and Gr1 were usually expressed in <0.5% of thymic ripheral chimerism dropping below 0.2% or even becoming undetectable remained in a hyporesponsive state cells (Fig. 1B, D) . Interestingly, higher levels of peripheral chimerism correlated with lower percentages of to the donor. Therefore, the immune response of mixed Each chimerism group had similar first month chimerism levels for its subgroups [p = 0.377 for M1(<0.5) in blue, p = 0.927 for M1(0.5-1.99) in red, and p = 0.724 for M1( ≥ 2) in green], (C) but significantly lower chimerism levels for ST2 or ST6, compared with ST1 (p < 0.001 for all groups). Circles are outlier values. (D) In Kaplan-Meier survival analyses of donor skin grafts, M1( ≥ 2)ST1 had better graft survivals than M1( ≥ 2)ST2 (p = 0.009) and M1( ≥ 2)ST6 (p = 0.001). M1(0.5-1.99)ST1 and M1(0.5-1.99)ST2 also compared favorably in graft survivals with M1(0.5-1.99)ST6 (p = 0.002 and 0.033, respectively). However, there was no difference in graft survivals among M1( ≥ 2)ST2, M1( ≥ 2)ST6, M1(0.5-1.99)ST1, and M1(0.5-1.99)ST2. Neither was there significant difference among M1(0.5-1.99)ST6, M1(<0.5)ST1, and M1(<0.5)ST2 despite that they all had better graft survivals compared with untransplanted controls (p < 0.001). chimeras to the donor could be presaged as "reliable tol-ceived skin transplantation with first month chimerism levels of 0.13-0.66%, were sacrificed by 2 months of erance," "possible tolerance," and "hyporesponsiveness" based upon peripheral chimerism of >3%, 0.2-3%, and age. Recipients without skin transplantation were grouped as peritoneal chimerism(−) when there was no <0.2% at the time of graft placement, respectively. evidence of chimerism in any tissue examined, but Follow-up of Peripheral Chimerism and Reappraisal of grouped as peritoneal chimerism(+) when only peritothe Tolerant State by Secondary Skin Transplantation neal donor cells were detected (0.43-2.25%) at sacrifice by 2 month of age. All groups exhibited syngeneic non-In total, 38 mixed chimeras tolerated donor skin for more than 120 days (Table 1 ). By the age of 12 months, reactivity but third-party alloreactivity. Low-level chimerism rendered host lymphocytes unresponsive to do-24 tolerant mice lost circulating donor cells, but kept syngeneic and donor-specific skins in good shape ( Fig. nor alloantigens even in the cases of prior donor skin rejection, or specific peritoneal lodgment of donor leu-4A). Eight of them (Table 1) had their engrafted skins removed (Fig. 4A) , and received secondary skin trans-kocytes. These findings indicate that the lack of response of host lymphocytes in MLR does not fully pre-plants 1 month later, when circulating donor cells remained undetectable, to assess the role of engrafted do-dict the status of tolerance for allogeneic skin grafting. Exogenous IL-2 only partially restored the alloreac-nor skin in tolerance maintenance. Two mice died within 7 days after skin retransplantation ( Table 1) . The re-tivity of mixed chimeras in MLR (Fig. 4D ). However, subcutaneous injection of IL-2 beneath engrafted donor maining six had long-term acceptance (>120 days) of secondary syngeneic and donor-specific skin grafts ( Fig. skins up to an accumulated dose of 14 µg in two tolerant mice failed to cause graft rejection within an observation 4A), but showed accelerated rejection of secondary third-party C3H skin grafts compared with primary period of 30 days. third-party grafts (p = 0.021, data not shown). Engrafted
Analyses of Tissue Chimerism syngeneic, primary, and secondary donor skins had no histological evidence of rejection ( Fig. 4B ). Engraftment Twelve skin-tolerant mice ( Table 2 , group A) that lost peripheral chimerism were sacrificed to examine do-of secondary donor skins did not restore blood cell chimerism. In contrast to these results, 12 mixed chimeras nor cells in other lymphoid or hematopoietic tissues. Among them, three recipients, sacrificed at the ages of (0.05-2.48% donor cells) with prior rejection of donor skin also had their tolerance reevaluated by secondary 7, 20, and 22 months, showed no detectable donor cells in any tissue examined. These findings argue against the skin transplantation. They all rejected secondary donor skins with similar kinetics to primary donor grafts (p = need for persistent tissue chimerism to maintain a tolerant state once skin grafts have taken. Trace donor cells 0.334, data not shown).
could sometimes be detected in the thymus, lymph node, Alloreactivity of Host Lymphocytes and peritoneum but were entirely undetectable in the bone marrow and spleen. In comparison with recipients Proliferative responses of recipients' lymphocytes in four experimental groups were evaluated by MLR with that had rejected donor skins in the categories of "possible tolerance" (Table 2, group B) and "hyporespon-untransplanted mice as positive controls and recipients with skin tolerance as negative controls (Fig. 4C ). Chi-siveness" ( Table 2 , group C), tolerant mice (group A) exhibited similar or even lower donor cell levels in all meras without skin grafting, which had 0.10-0.46% chimerism at 1 month of age, were sacrificed for MLR with tissues examined. Therefore, chimerism in any lymphohematopoietic tissue alone was not sufficient to ensure chimerism levels of 0.01-0.18% by 2 month of age. Chimeras with graft rejection (on day 21-30), which re-a durable state of skin tolerance. . Multiple comparisons reveal that chimeras without skin grafting, chimeras with graft rejection, and peritoneal chimerism(+) had significantly lower SI than untransplanted controls (*p < 0.001), but comparable SI to recipients with skin tolerance (p = 0.371-0.890). (D) In four mixed chimeras (graft survivals of 32, 54, >120, and >120 days) with perceived unresponsiveness to C57BL/6 stimulators as assessed by MLR (p = 0.016, compared with four untransplanted mice by t-test), the supplement of IL-2 in MLR culture caused significant amplifications of SI to FVB/N (p < 0.001, one-way ANOVA), C57BL/6 (p = 0.005), and C3H (p < 0.001) stimulators, as observed in their untransplanted counterparts (p = 0.006, p = 0.001, and p < 0.001, respectively). The SI amplification by IL-2 was does responsive to C3H stimulators, but not to FVB/N and C57BL/6 stimulators. In mixed chimeras, the amplified levels of donor-specific SI by IL-2 was unable to catch up with those in control animals (p = 0.004 and 0.007, t-test), but at a level comparable to control SI in the absence of IL-2 (p = 0.432 and 0.188). All bar data are shown as 95% confidence interval for mean. As the strategy of hematopoietic chimerism is con- previous studies (5, 12, 34) , and also fits with the earlier 3-4 months after marrow transplantation. Robust skin *Mice tolerated donor skin for >120 days, but eventually lost periphtolerance also relates to splenic chimerism of 10% in eral chimerism. Nine were sacrificed at the age of 7-11 months and mice, but the chance for graft acceptance drops to half three at the age of 19-22 months. †Mice rejected donor skin after skin transplantation at peripheral chi-with approximately 5% chimerism (14). Measuring merism of 0.23-2.09% and were sacrificed at the age of 1.5-3.5 splenic chimerism is less clinically applicable because it months after donor skin rejection.
necessitates an invasive procedure. Moreover, a major ‡Mice rejected donor skin after skin transplantation at peripheral chimerism of 0.01-0.15% and were sacrificed at the age of 1. 5-2.5 concern in these studies is the difficulty in evaluating months after donor skin rejection. the confounding effects of preconditioning or immuno- §Three in group A and two each in groups B and C were not examined suppressive regimens on chimerism levels and test graft for Thy1 thymocytes.
¶ p = 0.022, Mann-Whitney U-test, compared with group A.
survivals.
Previously we have demonstrated that only durable peripheral chimerism lasting at least 6 months stood a Tregs in Mice With Skin Tolerance chance of inducing tolerance to skin grafts placed at 6 months of age (6) . Herein, we extend this observation We collected mice with skin tolerance but loss of peripheral chimerism, and mice with donor skin rejection and show that the timing of skin placement influenced graft acceptance with the critical parameter being the to analyze Treg numbers among their CD4 + T cells. Tolerant mice had significantly higher FoxP3 expression chimerism level at skin placement as opposed to a higher chimerism level at an earlier point in life prior to among peripheral and splenic CD4 + T-cell populations than nontolerant and untransplanted mice ( Fig. 5A-C) , skin grafting. As a result, high-level chimeras still rejected donor skins once they had lost chimerism by the suggesting increased Tregs in tolerant mice. Functional assays showed that Tregs from tolerant mice inhibited time skin grafting was performed (42) . Two possible mechanisms can be envisioned for this observation: tol-proliferative alloresponses in a nonspecific manner (Fig.  5D ). However, in vivo depletion of Tregs (Fig. 5E ) in erance fades along with a decline or loss of blood chimerism or complete tolerance fails to develop at lower three tolerant mice failed to cause rejection of engrafted donor skins within an observation period of 30 days. In or undetectable levels of chimerism. Although the belief has long been that peripheral chimerism is required for contrast, intravenous infusion of 5-7.5 × 10 7 naive host lymphocytes (23.96% T cells) abolished the tolerant tolerance maintenance (22,35), engrafted donor skins in our study persisted despite spontaneous regression of pe-induction in immunocompetent mice, as opposed to an immunosuppressed rat model of cyclosporine-induced ripheral chimerism. This argues against the necessity of circulating donor cells for enduring tolerance. Kanamoto tolerance (24). These observations mirror the phenomenon that transfusion or adoptive transfer of donor leuko-et al. (19) reported that engrafted H-2 d skin was rejected after depletion of H-2 b/d donor cells with H-2 a host lym-cytes with solid organ transplants induces prolonged allograft survivals instead of long-term graft tolerance (10, phocytes specifically sensitized to H-2 b haploidentical alloantigens but naive to H-2 d . Although skin rejection 36, 43, 44, 49) . Clonal deletion is well documented following toler-was ascribed to depletion of chimeric cells, our study shows that naive host lymphocytes could still cause skin ance induction through IUT (16) , and occurs effectively at a level as low as 1% intrathymic donor cells (42), rejection. Thus, the observed break of tolerance results from MHC incompatibility between the injected lym-which correlates well with a threshold of 3% peripheral chimerism in this study. The reduced CD3 high expres-phocytes and engrafted donor skin rather than depletion of chimeric cells. In fact, enduring graft tolerance fol-sions in the thymus of tolerant mice may represent another aspect of intrathymic T-cell deletion. These results, lowing the loss of peripheral chimerism was observed in nonhuman primates and in humans treated with si-together with a linear correlation between peripheral and thymic chimerism, strongly support the rationale for pe-multaneous marrow and renal transplants (20, 21, 37) , and ascribed to alloantigens present in the form of the ripheral chimerism as a surrogate marker of immune tolerance. Thus, a relevant effect of blood chimerism on surviving organ grafts that helped to maintain tolerance (20, 37, 45) . In this study, the removal of engrafted pri-tolerance induction appears to be its role in central tolerance induction, but persistent peripheral chimerism is mary donor skin in tolerant mice that had lost peripheral chimerism failed to break the state of tolerance. The ac-not relevant to the maintenance of skin tolerance. An important question raised is whether enduring skin toler-celerated rejection of secondary third-party C3H skin suggested sensitization of recipients' immunity to H-2 k ance relies upon chimerism outside the peripheral circulation. Specific peritoneal lodgment of donor cells is alloantigens, and proved the recipient's immunocompetence after skin retransplantation. Our results support commonplace following IUT (7-9). It reduces donorspecific alloreactivity of host lymphocytes in MLR, but that the failure of primary skin acceptance after spontaneous or experimental depletion of peripheral chimerism only minimally prolongs survivals of donor skin grafts (6) . Although tolerant mice could have a trace of donor was not attributable to the loss of tolerance but rather to the incapability of establishing sufficient tolerance at cells in the thymus at 7-8 months old (6), longer term follow-up in this study did not reveal detectable donor lower or undetectable chimerism levels. Therefore, complete tolerance does not develop until successful skin cells in any tissue examined. Hyporesponsive mice with delayed donor skin rejection did not always lose tissue engraftment has taken place at a sufficient level of hematopoietic chimerism.
chimerism. These animals could keep a vestige of donor cells, comparable to or even at higher levels than toler-In this regard, long-term complete tolerance resulted from the immunological consequences of hematopoietic ant animals. These observations indicate a dissociation between tissue chimerism and enduring skin tolerance, chimerism and skin grafting. This argument is strengthened by the fact that recipients losing peripheral chime-arguing against the idea that low-level tissue chimerism is solely responsible for the maintenance of complete rism did not accept donor skin unless there was prior donor skin engraftment. Primary skin grafting made re-tolerance.
As a vital mediator of peripheral tolerance in many cipients capable of accepting secondary skin transplants even in the absence of detectable chimerism. Hemato-systems, Tregs are regarded as essential for tolerance maintenance in situations where high-level chimerism is poietic chimerism not only rendered host lymphocytes specifically unresponsive to donor alloantigens in MLR not established or sustained in rodent models of postnatal bone marrow transplantation (26) . However, reports but also prevented hosts from rejecting secondary donor skin at an accelerated speed. These results support the pertaining to the role of Tregs in the maintenance of hematopoietic chimerism and tolerance have varied concept that donor cell chimerism attenuates or abolishes donor-specific T-cell alloreactivity so as to facili-greatly, depending upon the protocols or strategies used in their studies (47, 48) . T-cell clonal anergy may repre-tate the initial induction of tolerance through the tolerogenic effects of donor skin. It essentially agrees with the sent another mechanism of peripheral tolerance (1, 13, 50, 51) , wherein anergic T cells show profound defects proposition that inhibition of initial graft rejection by sufficient immunosuppression may allow the tolerogenic in their immune responses with inability to secret IL-2 and proliferate upon antigen recognition (13). Although properties of organ allografts to eventually prevail (2, 15, 40) . It appears that blood chimerism is not solely re-tolerant mice in this study exhibited increased expression of Tregs with alloreactivity suppression and partial sponsible for tolerance induction, but mechanistically has important immunomodulatory effects on tolerance reversal of alloreactivity by exogenous IL-2 in MLR, 
